Primary care referrals to nephrology in patients with advanced kidney disease.


Journal

The American journal of managed care
ISSN: 1936-2692
Titre abrégé: Am J Manag Care
Pays: United States
ID NLM: 9613960

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 25 9 2021
Statut: ppublish

Résumé

Optimizing care for patients with advanced kidney disease requires close collaboration between primary care physicians (PCPs) and nephrologists. Factors associated with PCP referral to nephrology were assessed in patients with estimated glomerular filtration rates (eGFRs) less than 30 mL/min/1.73 m2. Electronic health record review at an integrated health care network. Factors associated with referral status were identified using Fisher's exact tests, t tests, and multivariable logistic regression. Of 133,913 patients regularly seeing PCPs between October 2017 and September 2019, 1119 had a final eGFR less than 30 mL/min/1.73 m2 and were not on renal replacement therapy. Care was provided by 185 PCPs (61 practices). Analyses were restricted to the 97.1% (n = 1087) of patients who were African American or European American. Of these, 54.6% had not been referred to nephrology. Nonreferred patients had higher numbers of PCP visits (P = .004). In contrast, referred patients were younger, were more often African American, and had PCPs at the academic medical center (all P < .0001). Referred patients had more complex medical histories with higher Charlson Comorbidity Index scores, more hospitalizations, and greater numbers of inpatient days (all P < .0001). Analyses restricted to patients with serum creatinine concentration of at least 2 mg/dL yielded similar results. Age, number of hospitalizations, ancestry, academic physician, diabetic end-organ damage, peripheral vascular disease, and tumor status were independent predictors of nephrology referral. Impediments to appropriately timed nephrology referrals persist in patients with high likelihoods of progression to end-stage kidney disease. Improved access to nephrology care should be rapidly addressed to meet targets in the 2019 Executive Order on Advancing American Kidney Health.

Identifiants

pubmed: 33196280
doi: 10.37765/ajmc.2020.88526
pii: 88526
pmc: PMC9067238
mid: NIHMS1800803
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

468-474

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001420
Pays : United States

Références

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):893-899
pubmed: 29507006
JAMA. 2011 Apr 20;305(15):1553-9
pubmed: 21482743
Am J Kidney Dis. 2017 Nov;70(5):705-714
pubmed: 28811048
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
Clin Nephrol. 2010 Apr;73(4):260-7
pubmed: 20353733
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Am J Kidney Dis. 2001 Dec;38(6):1178-84
pubmed: 11728948
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8
pubmed: 30798791
JAMA. 2019 Dec 3;322(21):2104-2114
pubmed: 31703124
Am J Kidney Dis. 2001 Sep;38(3):494-501
pubmed: 11532680
JAMA. 2015 Feb 24;313(8):837-46
pubmed: 25710660
J Gen Intern Med. 2019 Jul;34(7):1228-1235
pubmed: 30993634
Nephrology (Carlton). 2008 Dec;13(8):730-6
pubmed: 19019170
Am J Kidney Dis. 2014 May;63(5):713-35
pubmed: 24647050
BMC Nephrol. 2011 Sep 26;12:47
pubmed: 21943241
Clin Kidney J. 2015 Dec;8(6):772-80
pubmed: 26613038
Am J Kidney Dis. 2003 Feb;41(2):310-8
pubmed: 12552491
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Kidney Int. 2018 Jun;93(6):1409-1416
pubmed: 29685497
Cochrane Database Syst Rev. 2014 Jun 18;(6):CD007333
pubmed: 24938824
Fam Pract. 2017 Aug 1;34(4):416-422
pubmed: 28334754

Auteurs

Barry I Freedman (BI)

Section on Nephrology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1053. Email: bfreedma@wakehealth.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH